Spinocerebellar Ataxia Type 3 Clinical Trials

23 clinical trials for Spinocerebellar Ataxia Type 3 across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias — RECRUITING
• A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD — RECRUITING · PHASE1
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — RECRUITING
• A Phase 1b/2a first-in-human, multicentre, randomized, double-blind, placebo-controlled study of multiple ascending dose (Part1) followed by an open-label extension (Part2) to assess the safety, tolerability, and pharmacokinetics of intrathecally administered S233107 in participants with spinocerebellar ataxia type 3 — NOT_YET_RECRUITING · PHASE2
• Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3 — NOT_YET_RECRUITING · NA
• Troriluzole in Adult Participants With Spinocerebellar Ataxia — ACTIVE_NOT_RECRUITING · PHASE3
• Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia — NOT_YET_RECRUITING · PHASE2
• Instrumented Data Exchange for Ataxia Study — COMPLETED
• Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia — COMPLETED · NA
• Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia — OTHER · NA
• STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia — TERMINATED · PHASE2
• Identification of Biomarkers in Spinocerebellar Ataxia 3 — COMPLETED
• Toxic fragments in post-mortem brain from SCA3 patients — OTHER
• A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 — TERMINATED · PHASE1
• Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 — OTHER · NA
• Repetitive Transcranial Magnetic Stimulation in SCA3 Patients — COMPLETED · NA
• Study of CAD-1883 for Spinocerebellar Ataxia — WITHDRAWN · PHASE2
• Neuropsychiatry and Cognition in SCA3/MJD — OTHER
• Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD — OTHER
• Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes — OTHER
• Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 — COMPLETED · PHASE2
• Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 — WITHDRAWN · PHASE2
• Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 — COMPLETED · PHASE2

Refine this search